Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Primary Open Angle Glaucoma - Pipeline Insight, 2023"clinical trials has been added to ResearchAndMarkets.com'soffering.

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Open-Angle Glaucoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive analytical report has been ...

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 ...